Effect of Riocigaut on Migraine Attack Induction and Cerebral Vasodilation in Migraine Patients.
Status:
Not yet recruiting
Trial end date:
2024-05-31
Target enrollment:
Participant gender:
Summary
This double-blind, randomized, placebo-controlled cross-over clinical trial aims to
investigate the effects of riocigaut on migraine inducing properties and cerebral arteries in
patients with migraine.